SEC Form 4 · accession 0001179110-17-011152
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Gonzalez
Officer — Chairman of the Board and CEO · Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 4, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Aug 3, 2017 | M | 65,861 | $51.42 | A | 342,353 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | M | 22,038 | $51.42 | A | 364,391 | D | |
| Common stock, $0.01 par value | Aug 3, 2017 | S | 65,826 | $71.00 | D | 298,565 | D | |
| Common stock, $0.01 par value | Aug 3, 2017 | S | 35 | $71.005 | D | 298,530 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 101 | $71.00 | D | 298,429 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 15,600 | $71.06 | D | 282,829 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 3,000 | $71.07 | D | 279,829 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 1,900 | $71.08 | D | 277,929 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 500 | $71.105 | D | 277,429 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 200 | $71.11 | D | 277,229 | D | |
| Common stock, $0.01 par value | Aug 4, 2017 | S | 737 | $71.13 | D | 276,492 | D | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 4,600 | I | By spouse | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 450 | I | By step-daughter | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 450 | I | By step-son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $51.42 | Aug 3, 2017 | M | 65,861 | D | Feb 20, 2017 | Feb 19, 2024 | Common stock | 65,861 | 215,169 | D |
| Option (right to buy)F2 | $51.42 | Aug 4, 2017 | M | 22,038 | D | Feb 20, 2017 | Feb 19, 2024 | Common stock | 22,038 | 193,131 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities.
- F2Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).